Home » Topics » BioWorld Science

BioWorld Science
RSS

Antiviral pyrazine derivatives in the Toyama pipeline

Oct. 9, 2001

Marine sponge-derived and synthetic antitumor compounds patented by Pharma Mar

Oct. 9, 2001

GSK developing inhibitors of Lp-PLA2 for atherosclerosis

Oct. 9, 2001

Tularik designs LXR receptor modulators and discusses possible uses thereof

Oct. 9, 2001

New adenosine A2A receptor agonists reported to be particularly useful in respiratory disorders

Oct. 9, 2001

ABX-CBL promising for the management of GVHD according to phase II trial

Oct. 9, 2001

Studies in transgenic mice demonstrate positive effects of AMPAkines in ADHD

Oct. 9, 2001

AMDL acquires combination immunogene therapy technology

Oct. 9, 2001

New triple therapy for H. pylori eradication submitted for approval on two fronts

Oct. 9, 2001

FDA grants orphan drug designation to Celgene's Revimid for multiple myeloma

Oct. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....